Early Cannulation Prosthetic Graft (Acuseal^™) for Arteriovenous Access: A useful option to provide a Personal Vascular access Solution

Abstract

Early experience with the GORE Acuseal is encouraging. Patency and bacteremia rates are at least comparable to standard polytetrafluoroethylene grafts. ecAVGs have permitted cannulation within 24 hours of insertion and line avoidance in the majority of patients. Nearly three-quarters of patients achieved a definitive "personal vascular access solution" from their ecAVG.